AlBilasi Thamer M, Alanazi Rawan Mahmoud, AlDhawi Lama F, Albathi Abeer Ali
Department of Otolaryngology - Head & Neck Surgery (ORL-H&N), Prince Sultan Military Medical City (PSMMC), Riyadh, Saudi Arabia.
A Medical Student College of Medicine, Dar Al Uloom University, Riyadh, Saudi Arabia.
Ear Nose Throat J. 2023 Sep 29:1455613231201028. doi: 10.1177/01455613231201028.
Olfactory dysfunction can negatively impact the quality of life and increase the risk of danger from warning odors. Various factors can cause olfactory dysfunction, including COVID-19 infection, which has increased anosmia cases. No medications are approved; however, recent studies have suggested that intranasal insulin could effectively treat olfactory dysfunction. To comprehensively evaluate the effectiveness and safety of intranasal insulin in treating olfactory dysfunction. PubMed, Google Scholar, and CENTRAL databases were searched using specific keywords, and the outputs were screened using the Rayyan AI system. Original research articles published without time frame limitations that reported the relevant outcomes were included. The reviewers performed the screening and data extraction, and any disagreements were resolved by a third senior author. This systematic review identified 66 references from 3 databases, with 45 articles meeting the criteria for review after duplicates were removed. Six articles met the inclusion criteria and were selected, including 177 subjects. The selected studies consisted of various study designs, including pilot studies, placebo-controlled trials, crossover studies, and randomized clinical trials. The findings showed that intranasal insulin therapy had beneficial effects on olfactory function. Specifically, improvements were observed in olfactory detection and discrimination in patients with post-COVID-19 anosmia, olfactory threshold performance in healthy participants, and odor identification in hyposmic patients. However, there were variations in the observed effects based on different doses of insulin administered and gender differences. It also shows that using insulin provides good outcomes. Using it intranasally was safe and did not cause any complications. Intranasal insulin has shown promising results as a potentially safe treatment for olfactory dysfunction. Studies suggest that it can improve olfactory thresholds. Further studies are needed to investigate optimal doses and potential gender differences in response.
嗅觉功能障碍会对生活质量产生负面影响,并增加因警示气味而遭遇危险的风险。多种因素可导致嗅觉功能障碍,包括新冠病毒感染,该感染已导致嗅觉丧失病例增加。目前尚无获批的药物;然而,近期研究表明,鼻内注射胰岛素可有效治疗嗅觉功能障碍。为全面评估鼻内注射胰岛素治疗嗅觉功能障碍的有效性和安全性,使用特定关键词检索了PubMed、谷歌学术和CENTRAL数据库,并使用Rayyan人工智能系统对检索结果进行筛选。纳入无时间框架限制且报告了相关结果的原始研究文章。评审人员进行筛选和数据提取,如有分歧则由第三位资深作者解决。该系统评价从3个数据库中识别出66篇参考文献,去除重复文献后有45篇文章符合评审标准。6篇文章符合纳入标准并被选中,共涉及177名受试者。所选研究包括多种研究设计,如试点研究、安慰剂对照试验、交叉研究和随机临床试验。研究结果表明,鼻内胰岛素治疗对嗅觉功能有有益影响。具体而言,新冠病毒感染后嗅觉丧失患者的嗅觉检测和辨别能力、健康参与者的嗅觉阈值表现以及嗅觉减退患者的气味识别能力均有改善。然而,根据所给予胰岛素的不同剂量以及性别差异,观察到的效果存在差异。这也表明使用胰岛素能取得良好效果。经鼻使用胰岛素是安全的,未引起任何并发症。鼻内胰岛素作为一种潜在安全的嗅觉功能障碍治疗方法已显示出有前景的结果。研究表明它可改善嗅觉阈值。需要进一步研究以调查最佳剂量以及潜在的性别反应差异。